-
1دورية أكاديمية
المؤلفون: Bando, Hiroshi, Iwatsuki, N, Okada, M, Ogawa, T, Sakamoto, K
مصطلحات موضوعية: Super-low carbohydrate diet (LCD), Oral semaglutide (Rybelsus), Glucagon-like-peptide 1 receptor agonist (GLP1-RA), Sodium N-(8-[2-hydroxybenzoyl] amino) caprylate (SNAC), Peptide InnOvatioN for Early diabEtes tReatment (PIONEER)
-
2دورية أكاديمية
المؤلفون: Yamashita, H, Bando, Hiroshi, Kato, Y, Ogura, K, Sueki, E
مصطلحات موضوعية: Semaglutide (Rybelsus), Gastrointestinal adverse events (GIAEs), Glucagon-like-peptide 1 receptor agonist (GLP1-RA), Sodium N-(8-[2-hydroxybenzoyl] amino) caprylate (SNAC), Semaglutide Treatment Effect in People with Obesity (STEP), Peptide InnOvatioN for Early diabEtes tReatment (PIONEER)
-
3دورية أكاديمية
المؤلفون: Yamashita, H, Bando, Hiroshi, Kato, Y, Ogura, K, Kawata, T
مصطلحات موضوعية: Oral semaglutide (Rybelsus), Gastrointestinal adverse events (GIAEs), Semaglutide Treatment Effect in People with Obesity (STEP), Glucagon-Like Peptide 1 receptor agonist (GLP-1RA), Peptide InnOvatioN for Early diabEtes tReatment (PIONEER)
-
4دورية أكاديمية
المؤلفون: Bando, Hiroshi, Yamashita, H, Kato, Y, Ogura, K, Kawata, T
مصطلحات موضوعية: Glucagon-like peptide 1 receptor agonist (GLP-1RA), Oral semaglutide (Rybelsus), Oral hypoglycemic agents (OHAs), Sodium N-(8-[2-hydroxybenzoyl] amino) caprylate (SNAC), Japan LCD promotion association (JLCDPA)
-
5دورية أكاديمية
المؤلفون: Miki, K, Bando, Hiroshi, Hayashi, K, Dohi, A, Kamoto, A
مصطلحات موضوعية: Glucagon-like peptide 1 receptor agonists (GLP-1 RAs), Oral semaglutide (Rybelsus), Sodium N-(8-[2-hydroxybenzoyl] amino) caprylate (SNAC), Fasting time period
-
6دورية أكاديمية
المؤلفون: Bando, Hiroshi
مصطلحات موضوعية: Standards of Medical Care in Diabetes-2022, American Diabetes Association (ADA), Atherosclerotic cardiovascular disease (ASCVD), Chronic kidney disease (CKD), Glucagon-like peptide 1 receptor agonists (GLP-1RAs), Sodium–glucose cotransporter 2 inhibitors (SGLT2i)
-
7
المؤلفون: Bando, Hiroshi
المصدر: SunText Review of Endocrine Care. 1(1):106
مصطلحات موضوعية: Sodium–glucose cotransporter 2 inhibitors (SGLT2i), Glucagon-like peptide 1 receptor agonists (GLP-1RAs), nutritional and metabolic diseases, Chronic kidney disease (CKD), Atherosclerotic cardiovascular disease (ASCVD), Standards of Medical Care in Diabetes-2022, American Diabetes Association (ADA)
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=jairo_______::8fe19d892901cc33073c0a56d1d3405eTest
http://repo.lib.tokushima-u.ac.jp/116815Test -
8مورد إلكتروني
مصطلحات الفهرس: Glucagon-like peptide 1 receptor agonists (GLP-1 RAs), Oral semaglutide (Rybelsus), Sodium N-(8-[2-hydroxybenzoyl] amino) caprylate (SNAC), Fasting time period, Journal Article, VoR
-
9مورد إلكتروني
مصطلحات الفهرس: Glucagon-like peptide 1 receptor agonist (GLP-1RA), Oral semaglutide (Rybelsus), Oral hypoglycemic agents (OHAs), Sodium N-(8-[2-hydroxybenzoyl] amino) caprylate (SNAC), Japan LCD promotion association (JLCDPA), Journal Article, VoR
-
10مورد إلكتروني
مصطلحات الفهرس: Standards of Medical Care in Diabetes-2022, American Diabetes Association (ADA), Atherosclerotic cardiovascular disease (ASCVD), Chronic kidney disease (CKD), Glucagon-like peptide 1 receptor agonists (GLP-1RAs), Sodium–glucose cotransporter 2 inhibitors (SGLT2i), Journal Article, VoR